Expressions and clinical significance of CD133 and CD44 in gastrointestinal stromal tumors tissues
10.3760/cma.j.issn.1008-1372.2015.11.028
- VernacularTitle:胃肠道间质瘤组织中CD133和CD44的表达及其临床意义
- Author:
Wangyong LI
;
Guofu CHEN
;
Xiaoyan YANG
;
Shaoliang HAN
;
Xiuling WU
- Publication Type:Journal Article
- Keywords:
Gastrointestinal stromal tumors/ME;
Antigens,CD44/ME;
Antigens,CD/ME;
Prognosis
- From:
Journal of Chinese Physician
2015;17(11):1698-1701
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expressions of CD133 and CD44 and their prognostic significance in gastrointestinal stromal tumors (GIST).Methods Streptavidin perosidase (SP) method of immunohistochemistry was used to detect expressions of CD133 and CD44 proteins in 42 cases of GIST, and the relationship between their expressions and tumor size, mitotic count were analyzed by univariate and multivariate factor analyses.Results The expressions of CD133 and CD44 proteins in GIST were 21.4％ (9/42) and 78.6％ (33/42), respectively.The expressions of CD133 and CD44 proteins were significantly correlated with tumor size and mitotic count (P ＜ 0.05).Univariate factor analysis showed that the overall survival of GIST patients with positive CD133 protein (23.2 months) was shorter than that of patients with negative CD133 protein(63.1 months) (P ＜ 0.05).The overall survival of GIST patients with negative CD44 protein (23.2 months) was shorter than that of patients with positive CD44 protein (63.3 months) (P ＜ 0.05).Multivariate factor analysis showed that tumor size, mitotic count and CD44 protein were independent prognostic indicators for survival time after operation.Conclusions The positive expressions of CD133 and CD44 proteins might be the prognostic factors of GIST patients.
